If you have ever read a journal name beginning with the word Nature and assumed every one of them carried the same prestige, you are not alone — and you are also mistaken. The Nature portfolio journals are not one journal but a layered family of more than 160 titles, ranging from the famously selective weekly that rejects roughly 92% of submissions to broad open-access “megajournals” that judge papers only on soundness. Understanding where each title sits is the single most useful thing a researcher can do before deciding where to submit.
This guide maps the entire structure: the flagship, the Nature-branded research journals, Nature Reviews, Nature Communications, Scientific Reports, the Communications series, partner and society journals, and the new 2026 launches. The goal is simple — by the end you should be able to look at any “Nature” title and know roughly what it is, who it is for, and what it costs.
In Simple Words
Think of the Nature portfolio as a pyramid. At the very top is one journal — Nature itself — which is the hardest to get into. Below it sit specialist research journals (like Nature Medicine or Nature Physics), then the large open-access journals (Nature Communications), and at the wide base, Scientific Reports, which accepts any scientifically sound paper regardless of how groundbreaking it is. The further down you go, the easier acceptance becomes and the more papers each journal publishes — but the lower the prestige per paper.
Quick Check
Q: A paper rejected by Nature is automatically forwarded to Scientific Reports. True or false?
A: False. A desk rejection from Nature does not automatically transfer down. Editors may suggest a Nature-branded specialty journal or Nature Communications, but you choose where to resubmit.

What the Nature Portfolio Actually Is
The Nature portfolio journals are the nature.com-branded titles published by Nature Portfolio, a division of Springer Nature formed after the 2015 merger of Nature Publishing Group with Springer Science+Business Media. The flagship, Nature, has been published weekly since 1869. Around it the publisher has built a structured family of more than 160 titles spanning the life, physical, clinical and social sciences.
It helps to separate three things people routinely confuse:
- Springer Nature — the parent company, which publishes thousands of journals across many imprints (Springer, BMC, Palgrave Macmillan, Adis, and Nature Portfolio).
- Nature Portfolio — the prestige division responsible for the nature.com journals specifically.
- The Nature-branded journals — the subset of titles that actually carry the word “Nature” in their name, which is itself only part of the portfolio (partner and society journals do not).
A title carrying the word “Nature” is therefore not a guarantee of flagship-level selectivity. The brand spans an enormous range, and the differences between tiers are large enough to change your acceptance odds by a factor of seven or more.
The Tiers of the Nature Portfolio, Explained
1. The flagship — Nature
The weekly multidisciplinary journal first published in 1869, edited by Magdalena Skipper. It carried a 2024 impact factor of 48.5 and publishes peer-reviewed research across all natural sciences. It is a hybrid journal: you can publish subscription-only at no charge, or pay for gold open access. Selectivity is extreme — only research with broad, paradigm-shifting significance clears the bar, and the great majority of submissions are desk-rejected without review.
2. Nature-branded research journals (the specialty titles)
These are the discipline-specific journals such as Nature Medicine, Nature Genetics, Nature Physics, Nature Biotechnology and dozens more. They apply the same rigorous editorial filter as the flagship but within a defined field. Interestingly, some of these have, in certain years, posted higher impact factors than Nature itself — Nature Genetics being the classic example, because the genetics community is very large and generates a high citation density.
3. Nature Reviews journals
Launched from 2000 onward, titles like Nature Reviews Drug Discovery and Nature Reviews Cancer do not publish primary research. They commission authoritative review and perspective articles that synthesise a field. They are among the highest-impact-factor publications in all of science, but for most researchers they are reading material rather than submission targets (most content is invited).
4. Nature Communications — the selective open-access journal
Created as a general-interest open-access journal and made fully open access in 2014, Nature Communications is the flagship Nature-branded OA title. It still applies a meaningful significance filter — acceptance rates sit in the high single digits (around 8%) — and carried a 2024 impact factor of roughly 15.7. It is the journal editors often suggest when a paper is excellent and sound but not quite broad enough for a specialty Nature title.
5. The Communications series
Below Nature Communications sits a family of field-specific open-access journals — Communications Biology, Communications Physics, Communications Medicine, Communications Chemistry, Communications Earth & Environment, and others. These are selective but pitched a tier below the specialty Nature journals, offering a credible open-access home for solid disciplinary work.
6. Scientific Reports — the soundness-only megajournal
At the wide base of the pyramid is Scientific Reports, one of the largest journals in the world. Its referees are asked to judge whether the science is technically sound and accurate — not whether it is novel or significant. Acceptance rates are around 57%, the 2024 impact factor was about 3.9, and turnaround is comparatively fast (roughly three weeks to first decision). It is the broadest legitimate landing spot inside the portfolio.

Nature Portfolio Tiers at a Glance
| Journal / Tier | What it publishes | Editorial filter | Access model |
|---|---|---|---|
| Nature (flagship) | Paradigm-shifting research, all natural sciences | Broad significance + novelty (~92% rejected) | Hybrid (subscription or gold OA) |
| Nature [Field] (specialty) | Field-leading research within one discipline | Significance within field | Hybrid |
| Nature Reviews | Commissioned reviews & perspectives | Mostly invited | Hybrid |
| Nature Communications | Significant research, all sciences | Significant + sound (~8% accepted) | Fully open access |
| Communications [Field] | Solid disciplinary research | Selective, one tier below specialty | Fully open access |
| Scientific Reports | Any technically sound study | Soundness only, no novelty test (~57% accepted) | Fully open access |
Impact factors and acceptance rates cited reflect 2024 JCR / publicly reported figures and shift year to year. Always confirm current values on the journal’s own page before submitting.
New Additions to the Nature Portfolio (2025–2026)
The portfolio is not static — Springer Nature adds titles every year to meet emerging research needs. Recent and upcoming launches are worth knowing about:
- Nature Health and Nature Sensors — two new Nature-branded journals launching in January 2026. Nature Health targets interdisciplinary research on health protection and disease prevention; Nature Sensors is the first selective multidisciplinary journal focused on sensors and sensing systems.
- Nature Reviews Clean Technology and Nature Reviews Biodiversity — launched in 2025.
- Nature Progress — a new fully open-access series opening for submission on 19 March 2026, beginning with Nature Progress Oncology and Nature Progress Brain Health, with more titles to follow.
For authors, new launches can be an opportunity: early-stage journals are often actively seeking submissions and can offer faster, more engaged editorial handling while still carrying Nature Portfolio editorial standards.
How to Choose the Right Nature Journal for Your Paper
Picking a tier is mostly an honest assessment of two things: how significant your finding is, and how much risk you can absorb. A practical decision sequence:
- Is the work broadly paradigm-shifting? If a non-specialist would find it newsworthy and the evidence is overwhelming, the flagship or a specialty Nature journal is defensible — but be ready for fast desk rejection.
- Is it significant within your field but not beyond it? A specialty Nature [Field] journal or Nature Communications is the realistic ceiling.
- Is it solid, complete disciplinary work? A Communications [Field] journal fits well and keeps you inside the OA portfolio.
- Is it sound but incremental, or do you need speed and a high acceptance probability? Scientific Reports is the broad, legitimate base.
Two cost realities matter. First, for labs without open-access mandates, the subscription flagship is paradoxically the cheapest route at $0 in article charges — while the fully OA journals carry article processing charges that can run into thousands of dollars. Second, check your institution’s transformative or read-and-publish agreements before submitting; they can waive or reduce APCs entirely.
A word of caution: the strength of the Nature brand makes it a target for imitation. Predatory publishers deliberately choose titles that echo legitimate journals to trick authors. Always verify a journal at nature.com directly, and treat unsolicited invitations to publish in “Nature-sounding” titles with scepticism. Our journal selection guide covers verification in detail.
How Editverse Helps You Target the Right Tier
Matching a manuscript to the correct Nature tier is a judgement call that benefits from an experienced second opinion. Editverse has supported authors across 80+ countries, with a 99.8% acceptance rate and 2,500+ papers handled since 2019. Our services map directly onto the decisions above:
Journal Selection
An evidence-based shortlist matched to your paper’s significance and scope, with desk-rejection risk flagged before you submit.
Manuscript Writing & Editing
Full manuscript development and language editing calibrated to the editorial standards of high-impact journals.
Publication Support
End-to-end support from submission through peer review and reviewer responses until acceptance.
Conclusion
The word “Nature” on a journal masthead tells you who publishes it, not how hard it is to get into. The Nature portfolio journals form a deliberate hierarchy — flagship, specialty, reviews, selective open access, the Communications series, and the soundness-only base of Scientific Reports — with acceptance odds, impact, and cost varying enormously across it. Read the tier before you read the title, match your paper honestly to where it belongs, and verify every journal at its source. Do that, and the portfolio stops being a confusing wall of similar names and becomes a clear map of where your work can land.
About This Guide
This article was prepared by the Editverse editorial team, which has supported manuscript preparation and journal selection for researchers in over 80 countries since 2019. Journal structures, impact factors, acceptance rates, and APCs change over time; figures here reflect publicly reported 2024–2026 data and should be confirmed against each journal’s official nature.com page before submission. Editverse maintains an AI use and verification policy covering how AI-assisted content is checked.
References & Sources
- Nature Portfolio. “Nature Portfolio journals.” Springer Nature. springernature.com
- Springer Nature Group. “Nature Health and Nature Sensors announcement.” group.springernature.com
- Springer Nature. “Introducing Nature Progress.” springernature.com
- “Nature (journal).” Wikipedia. en.wikipedia.org
- “Nature Portfolio.” Wikipedia. en.wikipedia.org
